All stock lists
Quantinuum Inc. (NASDAQ:QNT)
US · Delayed Price · Currency is USD
Technology · Computer Hardware
$35.40-$2.06 (-5.50%)
Market cap
$9.32B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 4, 2026
Website
Insider Score
––Not scored
QNT Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From QNT’s reported statements · Q3 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $29.3M
- Net income
- -$141.3M
- Net margin
- -482.1%
Leverage19 / 20
Little or no net debt.
- Total debt
- $32.0M
- Cash
- $1.94B
- Debt / equity
- 0.07
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $1.99B
- Current liabilities
- $80.0M
- Current ratio
- 24.93
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$293.3M
- Free cash flow
- -$372.1M
- FCF margin
- -1269.6%
Dilution & runway13 / 20
Some dilution over the past year.
- Shares outstanding
- 36.8M
- Share growth (1y)
- 8.5%
- Cash runway
- 79 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
QNT Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $9.05 M | $8.00 M | $5.24 M | $7.02 M | $2.71 M | $2.11 M |
| Revenue Growth (YoY) | 233.33 % | 279.41 % | -72.56 % | — | — | — |
| Cost of Revenue | $3.19 M | $10.31 M | $1.83 M | $7.98 M | $1.06 M | $1.21 M |
| Gross Profit | $5.86 M | -$2.31 M | $3.41 M | -$953.00 K | $1.66 M | $903.00 K |
| SG&A Expense | $9.31 M | $181.24 M | $62.18 M | $104.99 M | $9.31 M | $9.48 M |
| R&D Expense | $42.38 M | $367.29 M | $74.72 M | $287.43 M | $42.38 M | $39.67 M |
| Operating Expenses | $138.67 M | $552.71 M | $141.09 M | $395.26 M | $54.53 M | $51.99 M |
| Operating Income | -$132.81 M | -$555.03 M | -$137.67 M | -$396.21 M | -$52.88 M | -$51.09 M |
| Pretax Income | -$118.21 M | -$595.95 M | -$132.87 M | -$428.83 M | -$51.91 M | -$56.92 M |
| Tax Provision | -$357.00 K | $569.00 K | $48.00 K | -$238.00 K | $130.00 K | $0.00 |
| Net Income | -$16.95 M | -$175.50 M | -$16.74 M | $67.91 M | -$52.04 M | -$56.92 M |
| EPS (Basic) | -$0.46 | -$1.93 | -$0.48 | $0.00 | -$1.53 | -$1.64 |
| EPS (Diluted) | -$0.46 | -$1.93 | -$0.48 | $0.00 | -$1.53 | -$1.64 |
| Shares Outstanding | 36.81 M | 33.91 M | 34.66 M | 0.00 | 33.94 M | 34.66 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.